{"id":"W2565606062","doi":"10.1182/blood.v110.11.734.734","title":"Efficacy of Dasatinib in Patients with Chronic-Phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-Year Follow-Up Data from START-C (CA180-013).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Chronic myelogenous leukemia; Internal medicine; Imatinib mesylate; Gastroenterology; Pharmacology; Oncology; Leukemia; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003913362,0.000551533,0.001020206,0.0002373637,0.00009469888,0.00002610496,0.0006967142,0.0001842565,0.0003242035],"category_scores_gemma":[0.000284034,0.0004037447,0.0000622514,0.0009078472,0.0001835931,0.0002352263,0.000236965,0.0004367537,0.000079693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002658607,"about_ca_system_score_gemma":0.003498913,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001154561,"about_ca_topic_score_gemma":0.02467883,"domain_scores_codex":[0.9958892,0.00006961584,0.0009551084,0.001182071,0.0009847541,0.0009192413],"domain_scores_gemma":[0.9959705,0.0003386295,0.0004287389,0.002649797,0.0002228695,0.000389403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1827314,0.02045684,0.7156959,0.002258641,0.004513251,0.003139235,0.007374822,0.0003466561,0.01186477,0.00008488676,0.003501565,0.04803208],"study_design_scores_gemma":[0.3558275,0.01250458,0.6012231,0.00420411,0.001200338,0.00002376451,0.0001985985,0.0001200833,0.0197594,0.000009761922,0.003947354,0.0009814915],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947235,0.000836418,0.0003494746,0.0000611683,0.0001025088,0.002490553,0.0007335734,0.00009859472,0.0006042034],"genre_scores_gemma":[0.982512,0.00004185744,0.01484856,0.0001086252,0.0002563884,0.0000596055,0.001565506,0.000131863,0.0004756289],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1730961,"threshold_uncertainty_score":0.9998415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02252274156858766,"score_gpt":0.2861795180592287,"score_spread":0.2636567764906411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}